The Clean Air Act: Improving public health at an affordable cost

By Michael Squires At its core, the Clean Air Act (CAA) is a health care statute. Congress found that “the growth in the amount and complexity of air pollution brought about by urbanization, industrial development, and the increasing use of motor vehicles, has resulted in mounting dangers to the public health and welfare.”[1] In 1990 […]

President Trump’s Proposed Budget Cuts to the National Institutes of Health

By Alexis Juergens for BioLawToday.org. President Trump released his preliminary 2018 budget plan on March 15th. While the budget plan proposes decreased federal funding in several areas, one of the agency’s receiving a cut in their budget is the National Institute of Health (“NIH”). The budget proposes to reduce NIH funding by 18%; this equates […]

Reproductive rights and equality under challenge in the U.S.

By Leslie Francis, originally posted on OUPblog.  For the over 40 years since the U.S. Supreme Court’s decision in Roe v. Wade that people have a constitutionally protected interest in deciding whether or not to reproduce, reproductive rights have been a persistent flashpoint of controversy in the United States. The controversy has been characterized by more heat […]

Governing Digitally Integrated Genetic Resources

By Jorge Contreras for BiolawToday.org.  In a recent case, a French research institute agreed to share the benefits arising from a drug patent with an indigenous group in French Guinea. The French researchers had learned about the medicinal plant from members of the Kali’na, Palikur, and Creole communities, but failed to negotiate access and benefit sharing […]

New research explores impact of broadening CRISPR patents

New research published by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras in the journal Science proposes that universities currently holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   “Because the potential for […]

Melinda Fagan on The Battle for CRISPR

By Justin R. Hamady for BiolawToday.org. On October 20th, the Center for Law and Biomedical Sciences at the S.J. Quinney College of Law, hosted guest speaker Melinda Fagan. Fagan holds the Sterling McMurrin Chair in the Department of Philosophy at the University of Utah and focuses her research on the philosophy of science, including explanation […]

New research explores impact of broadening CRISPR patents

New research published by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras in the journal Science proposes that universities currently holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   “Because the potential for […]

Children’s School Lunches: Their History and Potential Future

By Alexis Juergens for BiolawToday.org. In 1946, Congress passed the National School Lunch Act. This act states that “It is hereby declared to be the policy of Congress, as a measure of national security to safeguard the health and well-being of the Nation’s children and to encourage the domestic consumption of nutritious agricultural commodities and other food, […]

President Trump Reinstates the Mexico City Policy a.k.a “Global Gag Rule”

President Trump Reinstates the Mexico City Policy a.k.a “Global Gag Rule”: Is this constitutional under USAID v. Alliance for Open Society? By Kendra Brown for BiolawToday.org. Title X of the Public Health Services Act regulates the reward of grants that can be provided to foreign health providers that provide family planning services.[1] Section 300a-6 provides […]

First Major Revision to Common Rule for Human Subjects Research Released

On January 18, 2017, the Obama Administration finalized the first major overhaul of the so-called Common Rule for human subjects research which was first adopted in 1991.  The new rule applies to twenty different federal agencies funding research on human subjects, including the Department of Health and Human Services (which includes the National Institutes of […]